FLUDARABINE-MELPHALAN-CAMPATH FOLLOWED BY UNMANIPULATED PERIPHERAL-BLOOD HAEMATOPOIETIC STEM CELLS CAN STILL CURE LYMPHOMA.

FLUDARABINE-MELPHALAN-CAMPATH FOLLOWED BY UNMANIPULATED PERIPHERAL-BLOOD HAEMATOPOIETIC STEM CELLS CAN STILL CURE LYMPHOMA.

Background: The second decade of this millennium was characterized by a widespread availability of chimeric antigen receptor T-cell (CAR-T)therapies to treat relapsed and refractory lymphomas. As expected, the role and indication of allogeneic haematopoietic stem cell transplant(allo-HSCT)in the...

Full description

Saved in:

Bibliographic Details
Main Authors:	Daniele Avenoso, Amal Alabdulwahab, Michelle Kenyon, Varun Mehra, Pramila Krishnamurthy, Francesco Dazzi, Ye Ting Leung, Sandra Anteh, Mili Naresh Shah, Andrea Kuhnl, Robin Sanderson, Piers Patten, Deborah Yallop, Antonio Pagliuca, Victoria Potter
Format:	Article
Language:	English
Published:	PAGEPress Publications 2023-06-01
Series:	Mediterranean Journal of Hematology and Infectious Diseases
Subjects:	Allogeneic hematopoietic cell transplantation Lymphoma
Online Access:	http://mjhid.org/index.php/mjhid/article/view/5334
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

HAPLOIDENTICAL TRANSPLANT WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE FOR ACUTE MYELOID LEUKAEMIA AND MYELODYSPLASTIC SYNDROMES PATIENTS: THE ROLE OF PREVIOUS LINES OF THERAPY.
by: Daniele Avenoso, et al.
Published: (2024-01-01)

Very late onset Post-Transplantation Lymphoproliferative Disorder (PTLD) after haematopoietic stem cell transplant (HCT) – A Clinical Case
by: Sharon Lionel, et al.
Published: (2024-04-01)

Intravitreal Melphalan for Vitreous Seeds: Initial Experience in China
by: Xunda Ji, et al.
Published: (2016-01-01)

Lower Number of Fludarabine Cycles in Patients with Lymphoid Malignancies
by: Donald Pasquale
Published: (2014-08-01)

The Haematopoietic Stem Cell Niche: New Insights into the Mechanisms Regulating Haematopoietic Stem Cell Behaviour
by: Andrew J. Lilly, et al.
Published: (2011-01-01)

Recurrent Acute Pulmonary Toxicity and Respiratory Failure Associated with Fludarabine Monophosphate
by: Corey Cutler, et al.
Published: (1997-01-01)

THROMBOTIC MICROANGIOPATHY IN HAEMATOPOIETIC CELL TRANSPLANTATION:AN UPDATE
by: Evi Stavrou, et al.
Published: (2010-10-01)

IN UTERO HAEMATOPOIETIC STEM CELL TRANSPLANTATION (IUHSCT)
by: Maria Concetta Renda, et al.
Published: (2009-12-01)

IN UTERO HAEMATOPOIETIC STEM CELL TRANSPLANTATION (IUHSCT)
by: Aurelio Maggio, et al.
Published: (2009-06-01)

THROMBOTIC MICROANGIOPATHY IN HAEMATOPOIETIC CELL TRANSPLANTATION:AN UPDATE
by: Hillard Michael Lazarus, et al.
Published: (2010-08-01)

Fludarabine Treatment of Patient with Chronic Lymphocytic Leukemia Induces a Digital Ischemia
by: Utku Erdem Soyaltin, et al.
Published: (2016-01-01)

In Situ Evaluation of Fludarabine-DNA Interaction Using a DNA-Electrochemical Biosensor
by: H. Eda Satana, et al.
Published: (2011-01-01)

Melphalan delivery and co-delivery nanoformulations for cancer therapy: A comprehensive review
by: Hamidreza Abdouss, et al.
Published: (2024-12-01)

PU.1 and Haematopoietic Cell Fate: Dosage Matters
by: Ka Sin Mak, et al.
Published: (2011-01-01)

Melphalan Culprit or Confounder in Acute Encephalopathy during Autologous Hematopoietic Stem Cell Transplantation?
by: Diógenes Alayón-Laguer, et al.
Published: (2012-01-01)

Hyperthermic Intraperitoneal Chemotherapy with Melphalan: A Summary of Clinical and Pharmacological Data in 34 Patients
by: Lana Bijelic, et al.
Published: (2012-01-01)

Choice of Unmanipulated T Cell Replete Graft for Haploidentical Stem Cell Transplant and Posttransplant Cyclophosphamide in Hematologic Malignancies in Adults: Peripheral Blood or Bone Marrow—Review of Published Literature
by: Shatha Farhan, et al.
Published: (2016-01-01)

Designing Microfluidic Devices to Sort Haematopoietic Stem Cells Based on Their Mechanical Properties
by: Mingming Du, et al.
Published: (2019-01-01)

Clinical profile of BK virus infection in haematopoietic stem cell transplant recipients
by: Vijayshree Muthukumar, et al.
Published: (2024-01-01)

Inferior Outcomes of Fludarabine–Cyclophosphamide–Rituximab Chemotherapy in Korean Chronic Lymphocytic Leukemia Patients with Concurrent Thrombocytopenia and Anemia
by: Tong-Yoon Kim, et al.
Published: (2025-01-01)

Oral Management of a Haematopoietic Stem Cell Transplant Recipient with Chédiak–Higashi Syndrome
by: Kasumi Shimizu, et al.
Published: (2021-01-01)

A Case of Severe Hemorrhagic Cystitis Caused by Melphalan with Successful Bladder Preservation by Ligation of Bilateral Internal Iliac Arteries
by: Takumi Takeuchi, et al.
Published: (2010-01-01)

Correction: Percutaneous hepatic melphalan perfusion: Single center experience of procedural characteristics, hemodynamic response, complications, and postoperative recovery
Published: (2024-01-01)

Long-term sildenafil therapy for pulmonary veno-occlusive disease in association with melphalan therapy for multiple myeloma: A case report
by: Christian Hesse, et al.
Published: (2024-11-01)

Vaccination After Haematopoietic Stem Cell Transplant: A Review of the Literature and Proposed Vaccination Protocol
by: André Silva-Pinto, et al.
Published: (2024-12-01)

Four cases of renal injury associated with allogeneic haematopoietic stem cell transplantation and literature review
by: Dong Ze-xuan, et al.
Published: (2025-01-01)

Impaired right ventricular function in long-term survivors of allogeneic haematopoietic stem-cell transplantation
by: Lars Gullestad, et al.
Published: (2021-12-01)

FLUDARABINE-BASED LOW-INTENSITY CONDITIONING FOR FANCONI ANEMIA IS ASSOCIATED WITH GOOD OUTCOMES IN APLASTIC ANEMIA BUT NOT IN MDS - A SINGLE-CENTER EXPERIENCE
by: Biju George, et al.
Published: (2023-06-01)

Hepatitis B Reactivation in a HBsAg-Negative, HBcAb-Positive Patient Receiving Fludarabine for the Treatment of Chronic Lymphocytic Leukaemia
by: Federica Toscanini, et al.
Published: (2011-01-01)

A Case of Hemophagocytic Lymphohistiocytosis in a Patient with Chronic Lymphocytic Leukemia after Treatment with Fludarabine, Cyclophosphamide, and Rituximab Chemotherapy, with Autopsy Findings
by: Ing S. Tiong, et al.
Published: (2012-01-01)

Cerebellar Neurocysticercosis as Long-Term Complication of Allogeneic Haematopoietic Stem Cell Transplantation from Haploidentical Donor
by: Federico Meconi, et al.
Published: (2019-01-01)

Prospective phase II study of allogeneic hematopoietic stem cell transplantation with targeted busulfan, fludarabine, and etoposide conditioning in pediatric acute lymphoblastic leukemia
by: Kyung Taek Hong, et al.
Published: (2024-12-01)

The Use of Etoposide, Ara-Cytarabine, and Melphalan (EAM) Conditioning Chemotherapy in Autologous Stem Cell Transplantation (ASCT) for a Patient with Relapsed Hodgkin’s Lymphoma
by: Eko A. Pangarsa, et al.
Published: (2021-01-01)

Unresectable Hepatic Metastasis of Uveal Melanoma: Hepatic Chemosaturation with High-Dose Melphalan—Long-Term Overall Survival Negatively Correlates with Tumor Burden
by: R. Brüning, et al.
Published: (2020-01-01)

Microcosting analysis of haematopoietic stem cell transplantation and chemotherapy with intermediate doses of cytarabine in the treatment of acute myeloid leukaemia
by: Sitânia Chiesa, et al.
Published: (2024-12-01)

NURSING MANAGEMENT OF HAEMORRHAGIC CYSTITIS IN PATIENTS UNDERGOING HAEMATOPOIETIC STEM CELL TRANSPLANTATION: A MULTICENTRE ITALIAN SURVEY
by: alvisa palese, et al.
Published: (2019-08-01)

Haematopoietic Stem Cell Transplant Trends in Pakistan: Activity Survey from Pakistan Bone Marrow Transplant Group
by: Natasha Ali, et al.
Published: (2023-01-01)

Machine learning evaluation of intensified conditioning on haematopoietic stem cell transplantation in adult acute lymphoblastic leukemia patients
by: Tomoyasu Jo, et al.
Published: (2024-11-01)

Lesson learned in pediatric haploidentical transplantation in a low-resource environment: delivering melphalan IV and using low dose radiation reduce graft failure
by: Valentine Jiménez-Antolinez, et al.
Published: (2024-12-01)

Transcriptome analysis of beta-catenin-related genes in CD34+ haematopoietic stem and progenitor cells from patients with AML
by: Buket Altinok Gunes, et al.
Published: (2024-06-01)